Recent review on selective histone deacetylase inhibitors in cancer therapy

Advances in non-Hydroxamate based Histone Deacetylase Inhibitors as Anticancer Agents

Recent advances in dual-targeting HDAC inhibitors for cancer treatment

Histone Deacetylase Inhibitors in Cancer

HDAC as a cancer target: Various scaffolds based on HDAC inhibitors and an overview of their advances

Coumarin based-histone deactylace HADC inhibitors

Design ,Synthesis, Insilco Study and Biological Evaluation of New Coumarin-Oxadiazole Derivatives as Potent Histone Deacetylase Inhibitors

Design, synthesis, molecular docking study, and biological evaluation of salicylaldimine derivatives as potential histone deacetylases inhibitors (HDACi) and anticancer agents

Design, molecular docking, synthesis, and in vitro pharmacological evaluation of biomolecules-histone deacetylase inhibitors conjugates with carbohydrazide as a novel zinc-binding

Novel Mannich Bases Derived from 2-Substituted Benzimidazole and (Thio)Hydantoin Moieties as Potent Histone Deacetylase 6 (HDAC6) Inhibitors